newsfilter
← Latest News
Business Wire·

Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

  • Stoke Therapeutics (NASDAQ: STOK) announced that CEO Ian F. Smith will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, at 7:30 p.m. ET.
  • A live audio webcast of the presentation will be available on the company's Investors & News website, with a replay accessible for 30 days post-event.
  • The company's lead investigational medicine, zorevunersen, is a first-in-class disease-modifying treatment for Dravet syndrome currently in a Phase 3 study.
  • Stoke utilizes its proprietary TANGO approach to develop antisense oligonucleotides that selectively restore protein levels in diseases caused by haploinsufficiency.
  • The company is headquartered in Bedford, Massachusetts, with initial focus on central nervous system & eye diseases.